deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CELLESTIS LIMITED (ASX.CST)

ASX Announcements (courtesy of ASX)

20012002200320042005200620072008200920102011

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names

 

Shareholder links
Our website ranking of CST: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details
Address: Level 1, Office Tower 2 Chadstone Centre 1341 Dandenong Rd Chadstone, VIC 3148
Tel:  + 61 3 8527 3500 Fax: + 61 3 9568 6623

Date first listed: 24/04/2001
Company Secretary: Mr Brian Manuel

Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Research, develop and market QuantiFERON technology products for medical diagnosis and scientific research - the QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses using whole blood samples

delisted at the request of the Company under listing rule 17.11, following confirmation of the implementation of the scheme of arrangement by which QIAGEN Australia Holding Pty Ltd is now the sole shareholder in the Company

30/08/2011

we understand Cellestis shareholders received Scheme Consideration of $3.74 per Cellestis share from QIAGEN Australia Holding Pty Ltd and a Special Dividend of $0.06 per Cellestis Share, together representing Total Cash Payments of $3.80 per Cellestis share

30/08/2011

the securities of Cellestis Limited (the "Company") will be suspended from quotation at the close of trading today, 10 August 2011, at the request of the Company, following lodgement with ASIC of the court order approving the scheme of arrangement between the Company and its shareholders to effect the acquisition of the Company by QIAGEN Australia Holding Pty Limited

10/08/2011

we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Qiagen Australia Holdings Pty Limited to acquire shares - this corporate event may appear elsewhere in this company record

28/07/2011
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Ronald PitcherChairman
    Anthony RadfordManaging Director
    Brian ManuelCFO
    John BennettsDirector
    Antonino CatanzaroDirector
    James RothelDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    Date of first appointment, title may have changed.